Review



clfa antibody  (Cusabio)


Bioz Verified Symbol Cusabio is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cusabio clfa antibody
    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels <t>of</t> <t>SrtA</t> and <t>ClfA</t> in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.
    Clfa Antibody, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clfa antibody/product/Cusabio
    Average 93 stars, based on 1 article reviews
    clfa antibody - by Bioz Stars, 2026-05
    93/100 stars

    Images

    1) Product Images from "inhibitory effect of hyperin on Staphylococcus aureus pathogenicity though interactions with sortase A and sortase B"

    Article Title: inhibitory effect of hyperin on Staphylococcus aureus pathogenicity though interactions with sortase A and sortase B

    Journal: Scientific Reports

    doi: 10.1038/s41598-025-23458-1

    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels of SrtA and ClfA in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.
    Figure Legend Snippet: Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels of SrtA and ClfA in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.

    Techniques Used: Cell Culture, Staining, Expressing, Bacteria, Centrifugation, SDS Page



    Similar Products

    99
    ATCC anti clfa antibody atcc 29213tm
    Anti Clfa Antibody Atcc 29213tm, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti clfa antibody atcc 29213tm/product/ATCC
    Average 99 stars, based on 1 article reviews
    anti clfa antibody atcc 29213tm - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    93
    Cusabio clfa antibody
    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels <t>of</t> <t>SrtA</t> and <t>ClfA</t> in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.
    Clfa Antibody, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clfa antibody/product/Cusabio
    Average 93 stars, based on 1 article reviews
    clfa antibody - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    90
    Inhibitex clfa monoclonal antibody (mab) tefibazumab
    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels <t>of</t> <t>SrtA</t> and <t>ClfA</t> in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.
    Clfa Monoclonal Antibody (Mab) Tefibazumab, supplied by Inhibitex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clfa monoclonal antibody (mab) tefibazumab/product/Inhibitex
    Average 90 stars, based on 1 article reviews
    clfa monoclonal antibody (mab) tefibazumab - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Inhibitex clfa monoclonal antibody (mab) (tefibazumab, aurexis
    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels <t>of</t> <t>SrtA</t> and <t>ClfA</t> in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.
    Clfa Monoclonal Antibody (Mab) (Tefibazumab, Aurexis, supplied by Inhibitex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clfa monoclonal antibody (mab) (tefibazumab, aurexis/product/Inhibitex
    Average 90 stars, based on 1 article reviews
    clfa monoclonal antibody (mab) (tefibazumab, aurexis - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    86
    Danaher Inc his6 clfa
    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels <t>of</t> <t>SrtA</t> and <t>ClfA</t> in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.
    His6 Clfa, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/his6 clfa/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    his6 clfa - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc mouse anti-clfa 2a12.12 monoclonal antibody
    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels <t>of</t> <t>SrtA</t> and <t>ClfA</t> in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.
    Mouse Anti Clfa 2a12.12 Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-clfa 2a12.12 monoclonal antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    mouse anti-clfa 2a12.12 monoclonal antibody - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc mouse anti clfa 2a12 12 446 monoclonal antibody
    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels <t>of</t> <t>SrtA</t> and <t>ClfA</t> in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.
    Mouse Anti Clfa 2a12 12 446 Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti clfa 2a12 12 446 monoclonal antibody/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    mouse anti clfa 2a12 12 446 monoclonal antibody - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    90
    Inhibitex monoclonal antibody against clfa tefibazumab/aurexis
    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels <t>of</t> <t>SrtA</t> and <t>ClfA</t> in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.
    Monoclonal Antibody Against Clfa Tefibazumab/Aurexis, supplied by Inhibitex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monoclonal antibody against clfa tefibazumab/aurexis/product/Inhibitex
    Average 90 stars, based on 1 article reviews
    monoclonal antibody against clfa tefibazumab/aurexis - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Inhibitex passive antibody (no adjuvant) clumping factor a (clfa)
    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels <t>of</t> <t>SrtA</t> and <t>ClfA</t> in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.
    Passive Antibody (No Adjuvant) Clumping Factor A (Clfa), supplied by Inhibitex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/passive antibody (no adjuvant) clumping factor a (clfa)/product/Inhibitex
    Average 90 stars, based on 1 article reviews
    passive antibody (no adjuvant) clumping factor a (clfa) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Inhibitex affinity-purified clfa immune antibodies
    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels <t>of</t> <t>SrtA</t> and <t>ClfA</t> in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.
    Affinity Purified Clfa Immune Antibodies, supplied by Inhibitex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/affinity-purified clfa immune antibodies/product/Inhibitex
    Average 90 stars, based on 1 article reviews
    affinity-purified clfa immune antibodies - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels of SrtA and ClfA in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.

    Journal: Scientific Reports

    Article Title: inhibitory effect of hyperin on Staphylococcus aureus pathogenicity though interactions with sortase A and sortase B

    doi: 10.1038/s41598-025-23458-1

    Figure Lengend Snippet: Hyperin reduces biofilm formation, adhesion and cytotoxicity. ( a ) The absorbance at 600 nm of S. aureus USA300 when it was cocultured with various concentrations of hyperin. ( b ) Biofilm formation of S. aureus USA300 after treatment with different concentrations of hyperin. S. aureus USA300 was cultured with different concentrations of hyperin for 24 h, the samples were stained with 0.2% crystal violet, and the absorbance at 570 nm was measured after treatment with 35% glacial acetic acid. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( c ) Adhesion of S. aureus USA300 to lung epithelial cells when different concentrations of hyperin were added. A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 1.5 h, after which the cells were washed, harvested, plated onto LB agar medium and cultured. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. ( d ) Survival rate of A549 cells treated with hyperin. The data are shown as the mean and SD. ( e ) LDH levels in A549 cells and the survival of cells determined by live/dead staining ( f ). A549 cells were treated with S. aureus USA300 and different concentrations of hyperin for 6 h. The LDH levels in the supernatant were measured with an LDH kit, and the cells were stained with live/dead reagents. Data are shown as the mean with the SD, ** indicates p ≤ 0.01. The bar represents 50 μm. ( g ) The expression levels of SrtA and ClfA in S. aureus USA300 treated with different concentrations of hyperin. S. aureus USA300 was cocultured with different concentrations of hyperin, after which the bacteria were harvested by centrifugation and treated with SDS-PAGE loading buffer. The proteins were separated on a 10% gel and identified by specific antibodies. ( h ) Quantitative analysis of the expression levels of SrtA and ClfA ( i ). The analysis was performed with Image J 1.54 g. The data are shown as the mean and SD.** indicates p ≤ 0.01.

    Article Snippet: ClfA antibody (Cusabio, CSB-PA692021ZA01FLB, 1:1000), and SrtA antibody (cusabio, CSB-EP3093FLF, 1:3000).

    Techniques: Cell Culture, Staining, Expressing, Bacteria, Centrifugation, SDS Page